← Leaderboards
Gulab Zode
University Of Iowa
$8,352,014
Attributed
$11,012,697
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,012,697 · 7
By mechanism
R01$9,665,807 · 4
R00$739,784 · 1
R21$431,750 · 1
K99$175,356 · 1
Top collaborators
- Abbot Frederick Clark7 shared
- Val C Sheffield7 shared
- Swapnil K. Sonkusare4 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Val C Sheffield$29,509,881
- John H Fingert$7,300,582
- Michael G Anderson$5,875,752
- Robert J Deschenes$5,231,929
- Hua Sun$841,797
Others in their field
Top investigators on “Glaucoma”
- Rohit Varma · University Of Southern California$58,233,961
- Janey L Wiggs · Massachusetts Eye And Ear Infirmary$36,083,461
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$27,740,623
- Linda M Zangwill · University Of California San Diego$23,025,291
- Robert N Weinreb · University Of California, San Diego$21,784,031
Research focus
GlaucomaPathway InteractionsTrabecular Meshwork StructureMouse ModelPhysiologic Intraocular PressurePrimary Open Angle GlaucomaFunctional DisorderInsightChronicEndoplasmic Reticulum StressCellsBlindnessPreventResistancePathologicGeneticRisk FactorsAqueous HumorOcular HypertensionTissuesPathologyMyocilinLinkMutant
Grant awards (33)
Impaired TRVP4-eNOS signaling in TM contributes to glaucoma$447,890
R01 · FY2025 · EY · contact PI
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG$392,500
R01 · FY2025 · EY · contact PI
Impaired TRVP4-eNOS signaling in TM contributes to glaucoma$447,890
R01 · FY2024 · EY · contact PI
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG$392,500
R01 · FY2024 · EY · contact PI
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG$392,500
R01 · FY2024 · EY · contact PI
Development and characterization of an inducible model for myocilin POAG$196,250
R21 · FY2024 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$473,396
R01 · FY2023 · EY
Impaired TRVP4-eNOS signaling in TM contributes to glaucoma$447,890
R01 · FY2023 · EY · contact PI
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG$392,500
R01 · FY2023 · EY · contact PI
Development and characterization of an inducible model for myocilin POAG$235,500
R21 · FY2023 · EY · contact PI
Administrative Supplement for Research on Vitamin B3 Dietary Supplements for Eye Disease$149,340
R01 · FY2023 · EY
Novel Genome Editing for the Treatment of Glaucoma$459,195
R01 · FY2022 · EY
Impaired TRVP4-eNOS signaling in TM contributes to glaucoma$444,075
R01 · FY2022 · EY · contact PI
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG$370,000
R01 · FY2022 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$527,925
R01 · FY2021 · EY
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG$354,050
R01 · FY2021 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$477,939
R01 · FY2020 · EY
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG$361,320
R01 · FY2020 · EY · contact PI
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma$328,500
R01 · FY2020 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$70,857
R01 · FY2020 · EY
Novel Genome Editing for the Treatment of Glaucoma$491,564
R01 · FY2019 · EY
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG$365,000
R01 · FY2019 · EY · contact PI
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma$328,500
R01 · FY2019 · EY · contact PI
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma$199,976
R01 · FY2019 · EY · contact PI
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG$365,000
R01 · FY2018 · EY · contact PI
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma$328,500
R01 · FY2018 · EY · contact PI
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma$328,500
R01 · FY2017 · EY · contact PI
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma$328,500
R01 · FY2016 · EY · contact PI
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma$248,617
R00 · FY2016 · EY · contact PI
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma$242,242
R00 · FY2015 · EY · contact PI
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma$248,925
R00 · FY2014 · EY · contact PI
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma$87,678
K99 · FY2013 · EY · contact PI
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma$87,678
K99 · FY2012 · EY · contact PI